LDMCX Performance — Lord Abbett Emerging Markets Bond Fund, Class C
Data updated: 2026-03-13
LDMCX returned +13.19% over one year to Dec 2025. Annualised returns are +9.74% over 3 years and +1.34% over 5 years. Against its Emerging Markets Bond category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $132, against $132 for the category, and to $113 over one year, against $115. Volatility over the past three years was 6.61% a year. In the 12 months to Dec 2025 the fund took in a net $3.6M, and assets reached $122.66M.
LDMCX Growth of $100
What $100 invested in Lord Abbett Emerging Markets Bond Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Emerging Markets Bond category average over the same months.
| Period | LDMCX | Category average |
|---|---|---|
| 1 year (Jan 2025 – Dec 2025) | $113 | $115 |
| 3 years (Jan 2023 – Dec 2025) | $132 | $132 |
| 5 years (Jan 2021 – Dec 2025) | $107 | $112 |
| Since data start (Jul 2019 – Dec 2025) | $115 | $121 |
LDMCX Trailing Returns
Total returns to Dec 2025, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +13.19% |
| 3 years (annualised) | +9.74% |
| 5 years (annualised) | +1.34% |
LDMCX Annual Returns
Calendar-year total returns of Lord Abbett Emerging Markets Bond Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2025 | +13.19% |
| 2024 | +6.47% |
| 2023 | +9.68% |
| 2022 | −16.28% |
| 2021 | −3.40% |
| 2020 | +4.12% |
| 2019 (Jul–Dec) | +3.12% |
LDMCX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | +1.6% | +1.4% | −1.3% | −1.0% | +1.1% | +2.6% | +1.3% | +1.6% | +2.0% | +2.2% | +0.4% | +0.6% |
| 2024 | −1.3% | +0.9% | +2.1% | −1.7% | +1.4% | +0.4% | +1.6% | +2.3% | +2.1% | −1.5% | +1.1% | −1.1% |
| 2023 | +3.1% | −2.6% | +0.6% | +0.6% | −0.7% | +1.9% | +1.9% | −1.8% | −2.6% | −1.4% | +5.7% | +4.9% |
| 2022 | −2.9% | −5.5% | −0.1% | −5.9% | +0.1% | −6.6% | +3.1% | −0.9% | −6.6% | +0.1% | +8.0% | +0.6% |
| 2021 | −1.2% | −2.4% | −1.3% | +2.1% | +1.1% | +0.5% | +0.3% | +0.9% | −2.4% | +0.1% | −2.5% | +1.5% |
| 2020 | +1.3% | −1.0% | −15.9% | +2.9% | +6.7% | +3.6% | +3.3% | +0.9% | −2.2% | +0.1% | +4.2% | +2.0% |
| 2019 | — | — | — | — | — | — | +1.1% | −0.4% | −0.2% | +0.5% | −0.4% | +2.5% |
LDMCX Risk
Risk measures from monthly returns over Jan 2023 – Dec 2025.
- 3-year volatility (annualised): 6.61%
- 3-year Sharpe ratio: 0.79 (vs 4.5% risk-free rate)
- Best month: +5.70% (Nov 2023)
- Worst month: −2.60% (Sep 2023)
LDMCX Fund Flows
Monthly money in and out of Lord Abbett Emerging Markets Bond Fund, from SEC Form N-PORT.
- 12-month net flow: $3.6M
- 12-month gross sales (incl. reinvestments): $21.0M
- Sales ÷ redemptions: 1.21×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Dec 2025 | $1.8M | $1.2M | $546K |
| Nov 2025 | $2.0M | $2.1M | −$84K |
| Oct 2025 | $2.0M | $2.3M | −$269K |
| Sep 2025 | $1.5M | $899K | $609K |
| Aug 2025 | $1.4M | $3.7M | −$2.2M |
| Jul 2025 | $4.2M | $2.0M | $2.2M |
| Jun 2025 | $1.3M | $1.1M | $149K |
| May 2025 | $759K | $1.3M | −$493K |
| Apr 2025 | $1.9M | $558K | $1.3M |
| Mar 2025 | $1.9M | $1.3M | $613K |
| Feb 2025 | $1.2M | $608K | $598K |
| Jan 2025 | $1.1M | $446K | $645K |
LDMCX Assets Under Management
Net assets of Lord Abbett Emerging Markets Bond Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2025-12-31 | $122.66M |
| 2025-09-30 | $120.00M |
| 2025-06-30 | $115.16M |
| 2025-03-31 | $112.48M |
| 2024-12-31 | $110.19M |
| 2024-09-30 | $112.15M |
| 2024-06-30 | $110.16M |
| 2024-03-31 | $114.11M |
| 2023-12-31 | $114.61M |
| 2023-09-30 | $109.21M |
| 2023-06-30 | $117.62M |
| 2023-03-31 | $120.58M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.